Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103647575 | 10364757 | 5 | F | 2004 | 20160624 | 20140806 | 20160711 | PER | US-JNJFOC-20140800547 | JANSSEN | 0.00 | A | M | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103647575 | 10364757 | 1 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | VARIED DOSES OF 2 MG AND 4 MG | Y | U | 20272 | TABLETS | |||||||
| 103647575 | 10364757 | 2 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | VARIED DOSES OF 117 MG TO 234 MG | U | U | 22264 | INJECTION | |||||||
| 103647575 | 10364757 | 3 | SS | RISPERDAL CONSTA | RISPERIDONE | 1 | Intramuscular | N | 21346 | MICROSPHERES | |||||||||
| 103647575 | 10364757 | 4 | SS | INVEGA | PALIPERIDONE | 1 | Oral | VARIED DOSES OF 117 MG TO 234 MG | U | U | 21999 | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103647575 | 10364757 | 1 | Psychotic disorder |
| 103647575 | 10364757 | 2 | Product used for unknown indication |
| 103647575 | 10364757 | 3 | Psychotic disorder |
| 103647575 | 10364757 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103647575 | 10364757 | OT |
| 103647575 | 10364757 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103647575 | 10364757 | Blood testosterone decreased | |
| 103647575 | 10364757 | Dystonia | |
| 103647575 | 10364757 | Fatigue | |
| 103647575 | 10364757 | Gynaecomastia | |
| 103647575 | 10364757 | Hyperprolactinaemia | |
| 103647575 | 10364757 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103647575 | 10364757 | 1 | 2004 | 0 |